Amarantus and BSI Proudly Announce BIO CEO & President Jim Greenwood as Panelist for 3rd Alzheimer's Focused #C4CT Concussion...
July 22 2014 - 3:47PM
Brewer Sports International (BSI), a multi-faceted global sports
advisory firm, and Amarantus BioScience Holdings, Inc.
(OTCQB:AMBS), a biotechnology company focused on the discovery and
development of novel diagnostics and therapeutics related to cell
cycle dysregulation, endoplasmic reticulum stress,
neurodegeneration and apoptosis, are proud to announce the
Honorable Jim Greenwood, President & CEO of the Biotechnology
Industry Organization (BIO), as a panelist for the 3rd Alzheimer's
focused #C4CT (Coalition for Concussion Treatment) Concussion
Awareness Summit, powered by MDM Worldwide on Thursday, July 31,
2014, at the United Nations in New York City, NY.
"This Summit brings together a diverse range of thought leaders
focused on addressing one of the pressing medical challenges we
face," Greenwood said. "It offers the opportunity to dive deep into
the latest research, to highlight the policies needed to encourage
and incentive increased investment in new drugs and therapies and
to mobilize our efforts to increase awareness. It will be a
wide-ranging, informative and frank conversation, and one I am
greatly looking forward to participating in."
As President & CEO of BIO, Greenwood leads the world's
largest trade association representing biotechnology companies,
academic institutions, state biotechnology centers and related
organizations across the United States and in more than 30 other
nations. BIO members are involved in the research and development
of innovative healthcare, agricultural, industrial and
environmental biotechnology products. BIO also produces the BIO
International Convention, the world's largest gathering of the
biotechnology industry, along with industry-leading investor and
partnering meetings held around the world. Prior to BIO, Greenwood
held elected office for 24 years. He served in the Pennsylvania
House and Senate before being elected to the U.S. House of
Representatives.
The #C4CT Concussion Awareness Summit is being convened on July
31, 2014 to explore the potential link between TBI and Alzheimer's
disease. A diverse working group of clinicians, medical
researchers, policy makers, international diplomats, athletes,
celebrities, and philanthropic organizations will be assembled to
raise awareness, advance clinical research, and develop public
policy in order to address this major unmet medical need and public
health issue.
To register or for additional information, please visit
www.c4ctsummit.com. For further event questions, please contact
Lindsay Lommel at lindsay.lommel@thebrewergroup.com. For
sponsorship information please visit:
http://www.c4ctsummit.com/sponsorship-opportunities/.
About Amarantus BioScience Holdings, Inc.
Amarantus BioScience Holdings (AMBS) is a biotechnology company
developing treatments and diagnostics for diseases associated with
neurodegeneration and protein misfolding-related apoptosis. AMBS
has licensed Eltoprazine ("Eltoprazine"), a phase 2b ready
indication for Parkinson's Levodopa induced dyskinesia and Adult
ADHD. AMBS has an exclusive worldwide license to the Lymphocyte
Proliferation test ("LymPro Test(R)") for Alzheimer's disease and
owns the intellectual property rights to a therapeutic protein
known as Mesencephalic-Astrocyte-derived Neurotrophic Factor
("MANF") and is developing MANF-based products as treatments for
brain disorders. AMBS also owns intellectual property for the
diagnosis of Parkinson's disease ("NuroPro") and the discovery of
neurotrophic factors ("PhenoGuard"). Amarantus operations are
located at Janssen Labs @QB3 in San Francisco, CA. For further
information please visit www.Amarantus.com, or connect with the
Company on Facebook, LinkedIn, Twitter and Google+.
About Brewer Sports International
Brewer Sports International (BSI) is a multi-faceted sports
advisory firm within The Brewer Group Companies with a focus on the
business of sports, wellness and media for professional athletes,
sports agencies, public and private corporations and various
partners including international organizations, governments and
NGOs. Jack Brewer, five-year National Football League (NFL) veteran
and former three-team captain, launched BSI in Minneapolis and
expanded to New York, Dallas, Miami, Beijing and Malawi. BSI offers
a unique financial services platform to professional athletes and
sports agencies, as well as high-net-worth individuals and
businesses related to professional sports. BSI takes pride in
enabling its clients to capitalize on the endless opportunities
presented through sport. For more information, please visit
www.brewersports.com or follow them on Facebook, Twitter and
LinkedIn.
About MDM Worldwide
MDM Worldwide Solutions, Inc. is a digital communications agency
that develops and manages online engagement strategies to connect
companies with their stakeholders. MDM specializes in working with
clients in the technology, healthcare and life sciences spaces.
MDM's vast industry knowledge, proprietary methodology, proven
track record and experienced leadership team enables them to create
and customize targeted digital marketing campaigns to fulfill all
of their clients' objectives. For more information, please visit
mdmworldwide.com or find them on Facebook, Twitter, Google+ and
LinkedIn.
CONTACT: Brewer Sports International:
Kristi Hofacker, Director of Interactive Marketing and Media
651.247.4460
kristi.hofacker@thebrewergroup.com
Amarantus BioScience Holdings, Inc.:
Aimee Boutcher, Investor Relations
408.737.2734 x 101
ir@amarantus.com
Amarantus Bioscience (CE) (USOTC:AMBS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Amarantus Bioscience (CE) (USOTC:AMBS)
Historical Stock Chart
From Sep 2023 to Sep 2024